Sign in
HEPA Stock Price, Chart, Stats & News
Hepion Pharmaceuticals, Inc.
Save
Hepion Pharmaceuticals, Inc. (HEPA) does not currently pay a dividend.
873,278
Market cap
–
Current P/E
–
Forward P/E
HEPA chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Hepion Pharmaceuticals, Inc., a U. S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials.
Similar securities
Based on sector and market capitalization
Report issue